Correction to: Drugs - Real World Outcomes (2023) 10:631–637 https://doi.org/10.1007/s40801-023-00385-z
In the original publication of the article Fig. 1 was incorrect. The correct Fig. 1 is given below. In addition, a few corrections in the corresponding text is also given below. The original article has been corrected.
Anzeige
Figure 1, which appears as:
×
![]()
Should appear as:
×
![]()
Anzeige
Section 3.3 Assessment of Bone Union, first sentence, which reads:
Figure 1 shows the degree of bone union at 6 months after treatment. The percentage of patients with bone union and vertebral height maintained at ≥ 50% compared with that during the initial visit were 84.4%, 66.7%, 78.3%, and 40.0% in the DTPD, 2/WTPD, WTPD, and ROMO groups, respectively, with a lower percentage in the ROMO group compared with those of the other groups.
Should read:
Figure 1 shows the degree of bone union at 6 months after treatment. The percentage of patients with bone union and vertebral height maintained at ≥ 50% compared with that during the initial visit were 84.4%, 78.3%, 66.7% and 40.0% in the DTPD, 2/WTPD, WTPD, and ROMO groups, respectively, with a lower percentage in the ROMO group compared with those of the other groups.
Discussion, paragraph 4, sentence 3, which reads:
At 6 months after vertebral fracture, the number of patients with pseudarthrosis was 0 for both daily and twice-weekly administrations of TPD.
Should read:
At 6 months after vertebral fracture, the number of patients with pseudarthrosis was 0 for daily administrations of TPD.
Anzeige
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.